» Articles » PMID: 1968069

Narcolepsy

Overview
Specialties Neurology
Physiology
Date 1990 Jan 1
PMID 1968069
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Narcolepsy is a neurological condition with a prevalence of up to 1 per 1,000 that is characterized by irresistible bouts of sleep. Associated features include the pathological manifestations of rapid-eye-movement (REM) sleep: cataplexy, sleep paralysis, hypnagogic hallucinations, and abnormal sleep-onset REM periods and disturbed nocturnal sleep. The condition is strongly associated with the HLA-DR2 and DQw1 phenotype. The phenomenology of narcolepsy is discussed, and diagnostic procedures are reviewed. Treatment modalities involving central nervous system stimulants for somnolence and tricyclic drugs for REM-sleep abnormalities are discussed. Sleep laboratory studies on the treatment efficacy of methylphenidate, pemoline, dextroamphetamine, protriptyline, and viloxazine are presented. Data suggest that: (1) methylphenidate and dextroamphetamine objectively improve somnolence; (2) pemoline, at doses up to 112.5 mg, is less effective in controlling somnolence but may improve certain aspects of performance; and (3) protriptyline and viloxazine are effective anticataplectic agents that produce little improvement in somnolence.

Citing Articles

Comparative efficacy of sodium oxybate versus placebo on improvement of nighttime sleep in adult patients with narcolepsy: A systematic review and meta-analysis.

Arshad A, Qureshi M, Masood M, Zahoor H, Nazakat A, Fatima A Sleep Med X. 2025; 9():100136.

PMID: 39811427 PMC: 11728066. DOI: 10.1016/j.sleepx.2024.100136.


Recent Insights Into Sleep Paralysis: Mechanisms and Management.

Bhalerao V, Gotarkar S, Vishwakarma D, Kanchan S Cureus. 2024; 16(7):e65413.

PMID: 39184697 PMC: 11344621. DOI: 10.7759/cureus.65413.


Lisdexamfetamine to improve excessive daytime sleepiness and weight management in narcolepsy: a case series.

Aguilar A, Frange C, Pimentel Filho L, Reis M, Tufik S, Coelho F Braz J Psychiatry. 2019; 42(3):314-316.

PMID: 31859793 PMC: 7236164. DOI: 10.1590/1516-4446-2019-0544.


Treatment of Excessive Daytime Sleepiness in Patients with Narcolepsy.

Perez-Carbonell L Curr Treat Options Neurol. 2019; 21(11):57.

PMID: 31713736 DOI: 10.1007/s11940-019-0595-9.


Management Of Excessive Sleepiness In Patients With Narcolepsy And OSA: Current Challenges And Future Prospects.

Sahni A, Carlucci M, Malik M, Prasad B Nat Sci Sleep. 2019; 11:241-252.

PMID: 31695533 PMC: 6815780. DOI: 10.2147/NSS.S218402.


References
1.
Hill W . On Some Causes of Backwardness and Stupidity in Children: And the Relife of these Symptoms in Some Instances by Naso-Pharyngeal Scarifications. Br Med J. 2010; 2(1500):711-2. PMC: 2155685. DOI: 10.1136/bmj.2.1500.711. View

2.
Reinertsen J, Klippel J, Johnson A, Steinberg A, Decker J, Mann D . B-lymphocyte alloantigens associated with systemic lupus erythematosus. N Engl J Med. 1978; 299(10):515-8. DOI: 10.1056/NEJM197809072991004. View

3.
Kilduff T, Bowersox S, Kaitin K, Baker T, Ciaranello R, Dement W . Muscarinic cholinergic receptors and the canine model of narcolepsy. Sleep. 1986; 9(1 Pt 2):102-6. DOI: 10.1093/sleep/9.1.102. View

4.
Faull K, Radde L, Bowersox S, Baker T, Kilduff T, Dement W . Biogenic amine concentrations in the brains of normal and narcoleptic canines: current status. Sleep. 1986; 9(1 Pt 2):107-10. DOI: 10.1093/sleep/9.1.107. View

5.
Browman C, Gujavarty K, Sampson M, Mitler M . REM sleep episodes during the maintenance of wakefulness test in patients with sleep apnea syndrome and patients with narcolepsy. Sleep. 1983; 6(1):23-8. PMC: 2435606. DOI: 10.1093/sleep/6.1.23. View